Andrew Koff - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Andrew Koff

Showing results (41-50 of 45) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 45 results.

Cancer Cell|October 11, 2024

Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversionRei Kudo, Anton Safonov, Catherine Jones, et al.

Cancer Research Communications|December 1, 2025

Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated LiposarcomaEvan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar, et al.

Nature Communications|June 17, 2022

Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcomaSandra P D'Angelo, Allison L Richards, Anthony P Conley, et al.

Future Oncology (London, England)|July 29, 2024

The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancerKamilla Fjermeros, Salim Ghannoum, Stephanie B Geisler, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2023

Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated LiposarcomaCaroline E Gleason, Mark A Dickson, Mary E Klein Dooley, et al.

Pageof 5

Search research articles

Showing results (41-50 of 45) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 45 results.

Cancer Cell|October 11, 2024

Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversionRei Kudo, Anton Safonov, Catherine Jones, et al.

Cancer Research Communications|December 1, 2025

Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated LiposarcomaEvan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar, et al.

Nature Communications|June 17, 2022

Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcomaSandra P D'Angelo, Allison L Richards, Anthony P Conley, et al.

Future Oncology (London, England)|July 29, 2024

The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancerKamilla Fjermeros, Salim Ghannoum, Stephanie B Geisler, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2023

Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated LiposarcomaCaroline E Gleason, Mark A Dickson, Mary E Klein Dooley, et al.

Pageof 5